[HTML][HTML] Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective

V Kumar, S Kundu, A Singh, S Singh - Current neuropharmacology, 2022 - ncbi.nlm.nih.gov
Neurodegenerative diseases are a group of pathological conditions that cause motor inc-
ordination (jerking movements), cognitive and memory impairments result from …

Pathological role of HDAC8: cancer and beyond

JY Kim, H Cho, J Yoo, GW Kim, YH Jeon, SW Lee… - Cells, 2022 - mdpi.com
Histone deacetylase 8 (HDAC8) is a class I HDAC that catalyzes the deacetylation of histone
and non-histone proteins. As one of the best-characterized isoforms, numerous studies have …

The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective

B Mossink, M Negwer, D Schubert… - Cellular and Molecular …, 2021 - Springer
Neurodevelopmental disorders (NDDs), including intellectual disability (ID) and autism
spectrum disorders (ASD), are a large group of disorders in which early insults during brain …

Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system

T Grüter, N Mohamad, N Rilke… - Proceedings of the …, 2023 - National Acad Sciences
In inflammatory neuropathies, oxidative stress results in neuronal and Schwann cell (SC)
death promoting early neurodegeneration and clinical disability. Treatment with the short …

Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) …

SA Amin, S Khatun, S Gayen, S Das, T Jha - European Journal of Medicinal …, 2023 - Elsevier
Abstract Histone deacetylase 8 (HDAC8) aberrantly deacetylates histone and non-histone
proteins. These include structural maintenance of chromosome 3 (SMC3) cohesin protein …

The role of altered protein acetylation in neurodegenerative disease

F Kabir, R Atkinson, AL Cook, AJ Phipps… - Frontiers in Aging …, 2023 - frontiersin.org
Acetylation is a key post-translational modification (PTM) involved in the regulation of both
histone and non-histone proteins. It controls cellular processes such as DNA transcription …

A therapeutic perspective of HDAC8 in different diseases: an overview of selective inhibitors

A Fontana, I Cursaro, G Carullo, S Gemma… - International Journal of …, 2022 - mdpi.com
Histone deacetylases (HDACs) are epigenetic enzymes which participate in transcriptional
repression and chromatin condensation mechanisms by removing the acetyl moiety from …

OCT4 protein and gene expression analysis in the differentiation of spermatogonia stem cells into neurons by immunohistochemistry, immunocytochemistry, and …

D Hashemi Karoii, H Azizi - Stem Cell Reviews and Reports, 2023 - Springer
Abstract Background Spermatogonia Stem Cells (SSCs) are potential candidates for
reprogramming and regeneration. Recent studies have revealed that differentiated cells can …

Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis

YE Klingl, D Pakravan… - British Journal of …, 2021 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. ALS
patients suffer from a progressive loss of motor neurons, leading to respiratory failure within …

The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics

W Chen, L Guo, M Li, C Wei, S Li, R Xu - Brain Research, 2022 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with multiple complex
mechanisms involved. Among them, mitochondrial dysfunction plays an important role in …